RT @GeriPalBlog: #Dialysis vs Conservative Management for #OlderAdults: We discuss the pros/cons, effectiveness, tradeoffs, the need for mo….

⁦@StanfordNeph⁩ graduate student June Li mesmerizes the assembled crowd with her oral abstract from the RELATE consortium at #KidneyWk

As the editorialists @SofiaAhmedMD and @VictoriaRiehlT noted, let’s do better for our patients and give them more choices for managing chronic kidney failure. (my first tweet thread - hope I did it right).

I think these results, along with those of prior studies, are strong arguments that equipoise exists to test interventions like incremental dialysis start or responsive symptom management.

Important caveat—like most observational studies on this topic, we don’t know if symptoms differed between the group who started dialysis and those who continued medical mgmt. Some might say we need a clinical trial to answer these questions. I agree!.

those who started dialysis at this level of kidney function lived longer by 77 days, but they spent less time at home. The trade-offs between life expectancy and home time were more favorable for dialysis in groups who were older and had lower levels of kidney function.

We found that older patients who start dialysis when eGFR <12 ml/min live longer by a week than those who continue medical mgmt and could start dialysis later, but they spend 2 weeks less at home. Compared to those who forego dialysis completely, . .

To inform these decisions, we designed this target trial emulation study. @MontezRath.@vcharuMD.@DaceySeib.@ShipraAryaMD.@enricaf2.@annmohare.

We’ve been discussing dialysis but he’s undecided. Should we start dialysis soon, should we wait until his symptoms or kidney function worsen, or should he forego dialysis completely?.

He has cognitive impairment that is worse now, he’s experiencing fatigue, and his family says he’s not eating well – all symptoms that could be related to his kidney failure or other medical problems.

In my advanced CKD clinic, this is a common clinical encounter: Mr. Jones is 83 and has chronic kidney failure with a low eGFR. He’s not eligible for a transplant.

RT @MontezRath: Excited to share this important work with the community. Effect of Starting Dialysis Versus Continuing Medical Management….

RT @GoStanford: There's the world, and then there's Stanford. If Stanford were its own country, it'd be tied for 11th in event medals at #….

RT @JASN_News: SPRINT showed that intensive lowering of systolic BP increased the risk of incident CKD and episodes of AKI. A study looked….

RT @rajmehrotra1122: Tune in to the first Kidney Translation podcast, the ASN journal portfolio podcast. Thank you….

Excited to share work from @StanfordNeph @StanfordEpiNews PhD student June Li:. Representation of Real‐World Adults With Chronic Kidney Disease in Clinical Trials Supporting Blood Pressure Treatment Targets | Journal of the American Heart Association

RT @Carmendemigue12: What a better way to celebrate Valentine's day than with a #HYPHIP chat about treatment of #HTN in veterans with Kidne….

RT @JASN_News: Criteria to individualize glycemic targets in patients with type II diabetes are lacking. This study found heterogenous trea….

There were broad-based changes in #htn practice patterns contributing to a decline in BP control among adults with #CKD between 2011 and 2015 (i.e. before JNC8 was released), including fewer prescriptions of first-line therapies. #KidneyinCVD.

🙏 to the leadership of @rajmehrotra1122 @deboerih @ChoncholMichel and my @CJASN colleagues for the past 7 years, and so proud of what we’ve accomplished. Privileged to work with this amazing group.